Scientists launch national effort to unravel mysteries of rare blood disorder
NCT ID NCT04018118
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is collecting information from 600 people with chronically high levels of eosinophils (a type of white blood cell) or related organ damage. Researchers want to describe the different symptoms, disease patterns, and genetic factors involved. The goal is to better understand why some people develop this condition and how it changes over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Roger Salengro, CHU
RECRUITINGLille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New algorithm aims to speed up diagnosis of mysterious high white blood cell counts
- New COPD treatment cuts hospital returns in severe cases
- Air purifiers put to the test for COPD relief
- Drug dasatinib tested for rare blood cancers
- New clues to spot a rare blood disorder
- New hope for rare blood disorder: drug targets overactive immune cells